Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 10.8 mg/ml (equivalent: folinic acid, qty 10 mg/ml) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - leucovorin calcium injection usp is indicated following high dose methotrexate therapy to reduce toxicity (leucovorin rescue). it is also indicated after inadvertent overdosage with methotrexate and in impaired methotrexate elimination.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - calcium folinate, quantity: 16.2 mg (equivalent: folinic acid, qty 15 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections - leucovorin calcium has shown good results in the treatment of certain megaloblastic anaemias resulting from folic acid deficiency. this mainly occurs in infants, during pregnancy, in malabsorption syndromes, liver diseases, sprue and malnutrition. it is not more effective than folic acid for these conditions. leucovorin calcium has also shown good results in reducing the toxicity and circumventing the effect of folic acid antagonists, if therapeutically desired

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aa-med pty ltd - calcium chloride dihydrate, quantity: 1.286 g; magnesium chloride hexahydrate, quantity: 0.51 g; sodium chloride, quantity: 28.2 g; glucose monohydrate, quantity: 5.512 g (equivalent: glucose, qty 4.987 g); potassium chloride, quantity: 1.492 g - injection, solution - excipient ingredients: water for injections; dibasic sodium phosphate dihydrate; dilute hydrochloric acid - a continuous renal replacement therapy (crrt) replacement fluid used in intensive care units for the treatment of acute kidney injury.

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

aa-med pty ltd - calcium chloride dihydrate, quantity: 1.286 g; magnesium chloride hexahydrate, quantity: 0.51 g; sodium chloride, quantity: 28.2 g - injection, solution - excipient ingredients: water for injections; dibasic sodium phosphate dihydrate; dilute hydrochloric acid - a continuous renal replacement therapy (crrt) replacement fluid used in intensive care units for the treatment of acute kidney injury.

Malta - Inggeris - Malta Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, potassium chloride, sodium chloride - solution for infusion - sodium chloride 8.6 g/l potassium chloride 0.3 g/l calcium chloride dihydrate 0.33 g/l - blood substitutes and perfusion solutions

Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - sodium glycerophosphate hydrate, quantity: 6.122 g (equivalent: sodium glycerophosphate, qty 4.32 g) - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - glycophos? is indicated in adult and paediatric patients as a supplement to parenteral nutrition to meet the daily requirements of phosphate.

Malta - Inggeris - Malta Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, potassium chloride, sodium chloride, sodium lactate - solution for infusion - calcium chloride dihydrate 0.27 g/l potassium chloride 0.4 g/l sodium chloride 6 g/l sodium lactate 3.2 g/l - blood substitutes and perfusion solutions

Malta - Inggeris - Malta Medicines Authority

vocate pharmaceuticals s.a 150, gounari str, 166 74 glyfada, athens, greece - daptomycin - powder for solution for injection/infusion - daptomycin 350 mg - antibacterials for systemic use

Malta - Inggeris - Malta Medicines Authority

vocate pharmaceuticals s.a 150, gounari str, 166 74 glyfada, athens, greece - daptomycin - powder for solution for injection/infusion - daptomycin 500 mg - antibacterials for systemic use